FDA clears Vital Images CT TAVR planning app

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
 - FDA logo

Vital Images, part of the Toshiba Medical Systems Group, has received 510(k) clearance from the FDA for its CT TAVR (transcatheter aortic valve replacement) planning application. The company will showcase its TAVR planning application at the American College of Cardiology (ACC) annual scientific session, March 9-11 in San Francisco.

TAVR procedures are used to replace faulty aortic valves with artificial valves using endovascular techniques on patients who cannot withstand invasive surgeries. Vital's CT TAVR planning application is used in the planning process to visualize and measure vascular anatomy for the evaluation, treatment and follow-up of aortic vascular disorders.